Interpreting Key Trials
In this landmark trial, ACE inhibitors showed benefit beyond lowering blood pressure.
Reseach into biochemical derangements, and new therapies that prolong survival.
Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?
Theoretic reasons and small studies suggest the two types of drugs may be useful in combination, but a definitive answer awaits the results of...
These potent antiplatelet agents constitute a breakthrough, but questions remain about their safety, cost-effectiveness, and proper empiric use....
Letters To The Editor
Consider anticoagulation therapy for all patients with atrial fibrillation—intermittent or chronic—if they have risk factors for stroke.
Medical Grand Rounds
For the first time, we have the means to halt the progression of heart failure and reduce mortality—if we intervene early enough.
Unfractionated and low-molecular-weight heparins in acute coronary syndromes: Current recommendations
Most patients with acute coronary syndromes are candidates for heparin therapy. Low-molecular-weight heparin may offer advantages over standard,...